<?xml version="1.0" encoding="UTF-8"?>
<p id="d1e2190">The exact target of SARS-CoV-2 infection is not fully clear. Based on the findings from SARS-CoV, MERS-CoV 
 <xref rid="b18" ref-type="bibr">[18]</xref>, 
 <xref rid="b23" ref-type="bibr">[23]</xref>, 
 <xref rid="b24" ref-type="bibr">[24]</xref>, 
 <xref rid="b25" ref-type="bibr">[25]</xref>, 
 <xref rid="b26" ref-type="bibr">[26]</xref>, 
 <xref rid="b27" ref-type="bibr">[27]</xref>, 
 <xref rid="b56" ref-type="bibr">[56]</xref> and results from SARS-CoV-2 infection 
 <xref rid="b36" ref-type="bibr">[36]</xref>, 
 <xref rid="b57" ref-type="bibr">[57]</xref>, 
 <xref rid="b58" ref-type="bibr">[58]</xref>, SARS-CoV-2 can infect type II pneumocytes 
 <xref rid="b59" ref-type="bibr">[59]</xref>. Target cells (
 <italic>T</italic>) are assumed to be infected by SARS-CoV-2 (
 <italic>V</italic>) to generate infected cells (
 <italic>I</italic>) at a mass action rate 
 <inline-formula>
  <math id="d1e2215" display="inline" altimg="si23.svg">
   <mi>β</mi>
  </math>
 </inline-formula>VT. Infected cells die with a death rate 
 <inline-formula>
  <math id="d1e2220" display="inline" altimg="si25.svg">
   <mi>δ</mi>
  </math>
 </inline-formula>. They produce coronaviruses at a rate 
 <italic>p</italic> per infected cell. The virus is cleared at a constant rate 
 <italic>c</italic>.
</p>
